LVA repair with Dor procedure can be performed with low mortality. With appropriate repair of LVA and coronary revascularization, patients may have benefit both for survival and also for clinical status.
Creating a pericardial window may reduce late cardiac tamponade events/episodes, which may be a fatal complication in valve patients. We recommend performing this procedure by allocating some time during the surgical procedure in order to avoid tamponade.
Reduction of the diameter of STJ can be used to treat AI in patients with ascending aortic aneurysm with nearly normal aortic cusps. Midterm results of this procedure are encouraging.
A AB BS S T TR RA AC CT T O Ob bj je ec ct ti iv ve e: : In this study, we compared two different mitral valve replacement techniques (with and without papillary muscle resuspension via artificial chordae) in patients with rheumatic mitral valve disease; in regard to effects on left ventricular functions and sizes. M Ma at te er ri ia al l a an nd d M Me et th ho od ds s: : The study included 164 patients that underwent mitral valve replacement with the complete resection of the mitral valve and subvalvular apparatus due to rheumatic mitral valve disease between January 2010 and September 2015. First, the patients were classified into two different sections according to severety of mitral insufficiency. Then, those who underwent papillary muscle resuspension were compared with those who didn't in each section. R Re es su ul lt ts s: : Overall hospital mortality rate was 0.6% with 1 death. Among the patients who have significant mitral insufficiency, there was a significant difference between those with and without resuspension in respect to rates of inotrophic support taking and hospitalization duration times (59.2% versus 26.6%, p=0.033 and 10.59±5.8 versus 7.64±5.5 days , p= 0.036, respectively) in early postoperative period and ejection fractions (increased significantly in patients with resuspension from 56.23±9.1 to 59±6.5, while decreased in patients without resuspension from 58.37±9.9 to 57.07±9.1) during the mid-term postoperative period. C Co on nc cl lu us si io on n: : In the case of valve replacement in rheumatic mitral valve disease, if there is significant mitral regurgitation preoperatively, performing papillary muscle resuspension affects left ventricular systolic functions positively. So, resuspension of the papillary muscles can be considered as a favorable alternative to other valve sparing technique due to potential advantages of maintaining mitral annulopapillary muscle continuity. K Ke ey y W Wo or rd ds s: : Rheumatic heart disease; heart valve prosthesis implantation; chordae tendineae Ö ÖZ ZE ET T A Am ma aç ç: : Biz bu çalışmada romatizmal mitral kapaklı hastalarda iki farklı mitral kapak replasman tekniğini (yapay korda ile papiller kas resüspansiyonu yapılan ve yapılmayan) sol ventrikül fonksiyon ve boyutlarına etkileri bakımından karşılaştırdık. G Ge er re eç ç v ve e Y Yö ön nt te em ml le er r: : Çalışmaya Ocak 2010-Eylül 2015 arasında romatizmal mitral kapak hastalığı nedeni ile mitral kapak ve subvalvuler yapılar tamamen rezeke edilerek kapak replasmanı yapılan 164 olgu dahil edildi. İlk olarak hastalar preoperatif önemli mitral yetersizlik olup olmamasına göre 2 gruba ayrıldı. Sonra her grup içinde papiller kas resüspansiyonu yapılanlar yapılmayanlar ile karşılaştırıldı. B Bu ul lg gu ul la ar r: : Total mortalite 1 ölüm ile %0,6 idi. Önemli mitral yetersizliği olan hastalardan resüspansiyon yapılan ve yapılmayanlar arasında inotropik destek ihtiyacı ve hastanede kalış süreleri bakımından anlamlı farklılık vardı (%59,2'ye karşı %26,6, p=0,033 ve 10,59±5,8'e karşı 7.64±5.5 gün, p...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.